vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.
OneSpan Inc. is the larger business by last-quarter revenue ($65.9M vs $47.7M, roughly 1.4× IRONWOOD PHARMACEUTICALS INC). OneSpan Inc. runs the higher net margin — 17.5% vs -4.8%, a 22.3% gap on every dollar of revenue. On growth, OneSpan Inc. posted the faster year-over-year revenue change (4.1% vs -47.3%). Over the past eight quarters, OneSpan Inc.'s revenue compounded faster (4.0% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.
IRWD vs OSPN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $65.9M |
| Net Profit | $-2.3M | $11.6M |
| Gross Margin | — | 73.6% |
| Operating Margin | 14.3% | 22.5% |
| Net Margin | -4.8% | 17.5% |
| Revenue YoY | -47.3% | 4.1% |
| Net Profit YoY | -200.9% | — |
| EPS (diluted) | $0.01 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $65.9M | ||
| Q4 25 | $47.7M | $62.9M | ||
| Q3 25 | $122.1M | $57.1M | ||
| Q2 25 | $85.2M | $59.8M | ||
| Q1 25 | $41.1M | $63.4M | ||
| Q4 24 | $90.5M | $61.2M | ||
| Q3 24 | $91.6M | $56.2M | ||
| Q2 24 | $94.4M | $60.9M |
| Q1 26 | — | $11.6M | ||
| Q4 25 | $-2.3M | $43.5M | ||
| Q3 25 | $40.1M | $6.5M | ||
| Q2 25 | $23.6M | $8.3M | ||
| Q1 25 | $-37.4M | $14.5M | ||
| Q4 24 | $2.3M | $28.8M | ||
| Q3 24 | $3.6M | $8.3M | ||
| Q2 24 | $-860.0K | $6.6M |
| Q1 26 | — | 73.6% | ||
| Q4 25 | — | 73.6% | ||
| Q3 25 | — | 73.6% | ||
| Q2 25 | — | 73.5% | ||
| Q1 25 | — | 74.3% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 73.9% | ||
| Q2 24 | — | 66.2% |
| Q1 26 | — | 22.5% | ||
| Q4 25 | 14.3% | 19.9% | ||
| Q3 25 | 61.8% | 14.4% | ||
| Q2 25 | 53.2% | 17.6% | ||
| Q1 25 | -70.7% | 27.1% | ||
| Q4 24 | 34.8% | 19.3% | ||
| Q3 24 | 28.0% | 20.0% | ||
| Q2 24 | 26.5% | 12.5% |
| Q1 26 | — | 17.5% | ||
| Q4 25 | -4.8% | 69.2% | ||
| Q3 25 | 32.8% | 11.4% | ||
| Q2 25 | 27.7% | 13.9% | ||
| Q1 25 | -90.9% | 22.9% | ||
| Q4 24 | 2.5% | 47.1% | ||
| Q3 24 | 4.0% | 14.7% | ||
| Q2 24 | -0.9% | 10.8% |
| Q1 26 | — | $0.39 | ||
| Q4 25 | $0.01 | $1.13 | ||
| Q3 25 | $0.23 | $0.17 | ||
| Q2 25 | $0.14 | $0.21 | ||
| Q1 25 | $-0.23 | $0.37 | ||
| Q4 24 | $0.03 | $0.73 | ||
| Q3 24 | $0.02 | $0.21 | ||
| Q2 24 | $-0.01 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $49.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $272.0M |
| Total Assets | $396.9M | $383.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $49.8M | ||
| Q4 25 | $215.5M | $70.5M | ||
| Q3 25 | $140.4M | $85.6M | ||
| Q2 25 | $92.9M | $92.9M | ||
| Q1 25 | $108.5M | $105.2M | ||
| Q4 24 | $88.6M | $83.2M | ||
| Q3 24 | $88.2M | $77.5M | ||
| Q2 24 | $105.5M | $63.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — |
| Q1 26 | — | $272.0M | ||
| Q4 25 | $-261.8M | $271.8M | ||
| Q3 25 | $-264.2M | $238.3M | ||
| Q2 25 | $-308.2M | $242.5M | ||
| Q1 25 | $-334.1M | $231.1M | ||
| Q4 24 | $-301.3M | $212.5M | ||
| Q3 24 | $-311.3M | $194.6M | ||
| Q2 24 | $-321.7M | $178.6M |
| Q1 26 | — | $383.1M | ||
| Q4 25 | $396.9M | $397.7M | ||
| Q3 25 | $396.1M | $343.5M | ||
| Q2 25 | $342.9M | $357.1M | ||
| Q1 25 | $327.2M | $333.8M | ||
| Q4 24 | $350.9M | $338.7M | ||
| Q3 24 | $389.5M | $289.3M | ||
| Q2 24 | $395.6M | $286.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $28.2M |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 2.44× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $28.2M | ||
| Q4 25 | $74.6M | $12.6M | ||
| Q3 25 | $47.6M | $11.3M | ||
| Q2 25 | $-15.1M | $6.2M | ||
| Q1 25 | $20.0M | $29.4M | ||
| Q4 24 | $15.2M | $12.4M | ||
| Q3 24 | $9.9M | $14.0M | ||
| Q2 24 | $33.5M | $2.3M |
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $9.6M | ||
| Q3 25 | $47.6M | $8.8M | ||
| Q2 25 | $-15.1M | $4.4M | ||
| Q1 25 | $19.9M | $27.7M | ||
| Q4 24 | — | $10.5M | ||
| Q3 24 | $9.9M | $12.0M | ||
| Q2 24 | $33.4M | $26.0K |
| Q1 26 | — | — | ||
| Q4 25 | 156.3% | 15.3% | ||
| Q3 25 | 39.0% | 15.4% | ||
| Q2 25 | -17.7% | 7.3% | ||
| Q1 25 | 48.4% | 43.8% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | 10.8% | 21.4% | ||
| Q2 24 | 35.4% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 4.7% | ||
| Q3 25 | 0.0% | 4.4% | ||
| Q2 25 | 0.0% | 3.1% | ||
| Q1 25 | 0.1% | 2.6% | ||
| Q4 24 | 0.0% | 3.2% | ||
| Q3 24 | 0.0% | 3.5% | ||
| Q2 24 | 0.1% | 3.7% |
| Q1 26 | — | 2.44× | ||
| Q4 25 | — | 0.29× | ||
| Q3 25 | 1.19× | 1.74× | ||
| Q2 25 | -0.64× | 0.75× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | 6.74× | 0.43× | ||
| Q3 24 | 2.71× | 1.69× | ||
| Q2 24 | — | 0.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
OSPN
| Product and license | $35.5M | 54% |
| Services and other | $30.4M | 46% |
